A-Shares Concept Stocks Surge, Han Yu Pharmaceutical Up 14%, Jin Kai Biological Up 12%, Shen Nuo Biological Up 6%
Gracenote August 18 | A-share market concept stocks surge, among which Han Yu Pharmaceutical (300199) rises over 14%, Jin Kai Biological up over 12%, Shen Nuo Biological up 6%, Yang Guang Nuohao and S
Gracenote August 18 | A-share market concept stocks surge, among which Han Yu Pharmaceutical (300199) rises over 14%, Jin Kai Biological up over 12%, Shen Nuo Biological up 6%, Yang Guang Nuohao and ST Note up over 4%, Zhong Sheng Pharmaceutical (002317) and Kang Yuan Pharmaceutical (600557) up near 4%. On the news front, the US FDA has accelerated its approval of Han Yu's heavyweight therapeutic agent Wegovy (2.4 mg semiglutide) for supplemental new drug application (sNDA), used to treat adult patients with moderate to severe liver fibrosis and non-cirrhotic fatty liver disease-related metabolic disorders. As a result, the US stock market rose over 6% after hours.
